Schroders Capital to scale beyond $1 bn India bet, eyes consumer and healthcare deals
After deploying ~$1 billion over a decade across names like Lenskart, PineLabs and Giva, Schroders Capital is doubling down on India with $50 million average tickets in consumer, healthcare, tech and AI — leaning on secondaries and continuation vehicles as exit routes broaden beyond IPOs.
What happened
Schroders Capital plans to ramp up India investments after deploying ~$1 billion over a decade, targeting consumer, healthcare, tech and AI sectors, with
Key facts
- $1 billion deployed
- $50 million avg ticket
- 25% stake in Axis AMC
- $32.9 billion PE/VC exits
- $112 billion AUM
Why this matters
Well-capitalized strategic acquirers like Schroders portfolio companies will compete harder for mid-market consumer and healthcare assets, tightening valuation windows for bolt-ons.